Balyasny Asset Management
QTTB icon

Balyasny Asset Management’s Q32 Bio QTTB Stock Holding History

Balyasny Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-777
Closed -$23K – 3307
2022
Q3 		$23K Buy
777
+115
+17% +$4.69K ﹤0.01% 2567
2022
Q2 		$23K Buy
+662
New +$22.6K ﹤0.01% 2461
2020
Q2 		– Sell
-2,689
Closed -$752K – 1549
2020
Q1 		$752K Sell
2,689
-1,269
-32% -$389K 0.01% 824
2019
Q4 		$1.48M Buy
+3,958
New +$1.13M 0.01% 813

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Balyasny Asset Management's QTTB Position: Q4 2022 in Review

Balyasny Asset Management sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 777 shares — an estimated $23K sold.

Balyasny Asset Management first reported a position in QTTB in Q4 2019 and held it in 4 quarters. The position peaked at $1.48M in Q4 2019. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Balyasny Asset Management reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 777 Q32 Bio shares in Q4 2022, an estimated $23K.
  • Balyasny Asset Management first reported a position in Q32 Bio in Q4 2019 and held it in 4 quarters.
  • Balyasny Asset Management's Q32 Bio position peaked at $1.48M in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.